CHD4 insufficiency reduced immune suppression, as could be observed by elevated CD4+ and CD8+ T cell populations within the tumor, and enhanced the effectiveness of antitumor T-cell responses in melanoma-bearing mice treated with an anti-PD-1 antibody. The gene discussed is CD8A; the disease is neoplasm.